Stealth BioTherapeutics Company
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.
Investors
Founded Date:
2007
Total Funding:
$120M
Investor Type:
Company
Employee Number:
101-250
Funding Status:
IPO
Number Of Exists:
Post-IPO Equity
Technology:
Geroscience
Last Funding Type:
Post-IPO Equity
Investors Number:
8
Industry:
Oxidative Phosphorylation
Headquarters:
Cayman Islands
Estimated Revenue:
$10M to $50M